HomeCompareLSRCY vs JNJ

LSRCY vs JNJ: Dividend Comparison 2026

LSRCY yields 0.70% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSRCY wins by $1.49M in total portfolio value
10 years
LSRCY
LSRCY
● Live price
0.70%
Share price
$42.60
Annual div
$0.30
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.52M
Annual income
$1,191,934.13
Full LSRCY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LSRCY vs JNJ

📍 LSRCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSRCYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSRCY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSRCY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSRCY
Annual income on $10K today (after 15% tax)
$59.47/yr
After 10yr DRIP, annual income (after tax)
$1,013,144.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LSRCY beats the other by $1,009,158.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSRCY + JNJ for your $10,000?

LSRCY: 50%JNJ: 50%
100% JNJ50/50100% LSRCY
Portfolio after 10yr
$774.7K
Annual income
$598,311.76/yr
Blended yield
77.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LSRCY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
25.8
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSRCY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSRCYJNJ
Forward yield0.70%2.13%
Annual dividend / share$0.30$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1.52M$30.3K
Annual income after 10y$1,191,934.13$4,689.40
Total dividends collected$1.47M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: LSRCY vs JNJ ($10,000, DRIP)

YearLSRCY PortfolioLSRCY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,840$139.93$10,592$272.30+$248.00LSRCY
2$11,882$283.52$11,289$357.73+$593.00LSRCY
3$13,295$580.90$12,123$472.89+$1.2KLSRCY
4$15,440$1,214.88$13,141$629.86+$2.3KLSRCY
5$19,159$2,637.26$14,408$846.81+$4.8KLSRCY
6$26,616$6,116.49$16,021$1,151.60+$10.6KLSRCY
7$44,362$15,882.96$18,122$1,588.22+$26.2KLSRCY
8$96,949$49,481.86$20,930$2,228.20+$76.0KLSRCY
9$305,863$202,127.02$24,792$3,191.91+$281.1KLSRCY
10$1,519,207$1,191,934.13$30,274$4,689.40+$1.49MLSRCY

LSRCY vs JNJ: Complete Analysis 2026

LSRCYStock

Lasertec Corporation develops, manufactures, sells, and services semiconductor-related equipment, laser microscopes, and flat panel display-related equipment worldwide. The company provides systems used to inspect and measure defects on semiconductor photomasks and wafers; wafer related systems, such as SiC, GaN, multi-wavelength, and wafer edge inspection and review systems; wafer bump inspection and measurement systems; and TSV back grinding process measurement systems. It also offers flat panel display photomask inspection systems; laser microscopes, which are used for the observation and measurement of various materials and components comprising semiconductor materials, transparent films, coating materials, inorganic and organic materials, biological samples, metal parts, and plastic components; and lithium-Ion batteries. The company was formerly known as NJS Corporation and changed its name to Lasertec Corporation in 1986. Lasertec Corporation was founded in 1960 and is headquartered in Yokohama, Japan.

Full LSRCY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LSRCY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSRCY vs SCHDLSRCY vs JEPILSRCY vs OLSRCY vs KOLSRCY vs MAINLSRCY vs ABBVLSRCY vs MRKLSRCY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.